Literature DB >> 29331485

Impact of 9p21.3 region and atherosclerosis-related genes' variants on long-term recurrent hard cardiac events after a myocardial infarction.

German J Osmak1, Boris V Titov1, Natalia A Matveeva1, Vitalina V Bashinskaya1, Roman M Shakhnovich2, Tatiana S Sukhinina2, Nino G Kukava2, Mikhail Ya Ruda2, Olga O Favorova3.   

Abstract

Atherosclerotic coronary artery disease (CAD) and myocardial infarction (MI) as its most severe clinical complication remain the leading causes of mortality in the majority of countries. Despite the progress in the treatment of MI, quite often the patients, after the first-time MI, develop subsequently a variety of adverse cardiovascular events. In this retrospective study we evaluated the contribution of allelic variations in 9p21.3 locus and in 21 atherogenesis-related genes to the development of hard cardiac events in a cohort of patients of Russian ethnicity after the first acute MI during long-term follow-up (7-10 years). Death from cardiac causes and recurrent nonfatal MI were considered as key clinical outcomes. We have shown the association of rs1333049 and rs10757278 in 9p21.3 and MTHFR rs1801133 with recurrent unfavorable events, the latter was observed in time-dependent manner. Multilocus analysis additionally suggested the influence of carriage of the CRP and ENOS genes variants at the development of subsequent adverse events after MI. The composite model built for prediction of the individual genetic risk of postinfarction hard cardiac events included 9p21.3 rs1333049*GG and MTHFR*TT and was characterized by area under the curve (AUC) = 0.65. Our data show that 9p21.3 locus and MTHFR gene polymorphisms could influence long-term prognosis of recurrent hard cardiac events in patients who underwent the first MI. It is possible that addition of genotyping at such loci to existing clinical scores could improve their predictability.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  9p21.3 locus; Acute myocardial infarction; Genetic markers; Multilocus analysis; Recurrent cardiovascular events

Mesh:

Substances:

Year:  2018        PMID: 29331485     DOI: 10.1016/j.gene.2018.01.036

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Clinical study of serum procalcitonin level in patients with myocardial infarction complicated by pulmonary infection.

Authors:  Shiming Sun; Fengli Wang; Miao Yu; Jing Kang
Journal:  Exp Ther Med       Date:  2018-10-09       Impact factor: 2.447

2.  The association between the chromosome 9p21 CDKN2B-AS1 gene variants and the lipid metabolism: A pre-diagnostic biomarker for coronary artery disease.

Authors:  Şehime Gülsün Temel; Mahmut Çerkez Ergören
Journal:  Anatol J Cardiol       Date:  2019-01       Impact factor: 1.596

3.  Analysis of Polymorphism rs1333049 (Located at 9P21.3) in the White Population of Western Siberia and Associations with Clinical and Biochemical Markers.

Authors:  Elena Shakhtshneider; Pavel Orlov; Sergey Semaev; Dinara Ivanoshchuk; Sofia Malyutina; Valery Gafarov; Yuliya Ragino; Mikhail Voevoda
Journal:  Biomolecules       Date:  2019-07-19

4.  Association between rs3088440 (G > A) polymorphism at 9p21.3 locus with the occurrence and severity of coronary artery disease in an Iranian population.

Authors:  Mitra Pourgholi; Omid Abazari; Leyla Pourgholi; Maryam Ghasemi-Kasman; Mohammadali Boroumand
Journal:  Mol Biol Rep       Date:  2021-07-27       Impact factor: 2.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.